Science Explorer Back to mapMap
Discussion
Company · Shanghai · China

Genfleet Therapeutics (Shanghai) Inc. (China)

Research works
0
fractional, all time
Citations
0
Genfleet Therapeutics (Shanghai) Inc. (China)

Not ranked overall: Genfleet Therapeutics (Shanghai) Inc. (China) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

What are the most cited papers from Genfleet Therapeutics (Shanghai) Inc. (China)?

The most cited paper from Genfleet Therapeutics (Shanghai) Inc. (China) is "KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)" (Rafael Rosell, Jordi Codony‐Servat, Jessica González et al., 2023), with 36 citations. Next come "A phase I randomized, double‐blinded , placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects" (23) and "Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target" (21).

Most cited papers
#PaperReleasedCitations
1 KRAS G12C-mutant driven non-small cell lung cancer (NSCLC) Rafael Rosell, Jordi Codony‐Servat, Jessica González et al. · Critical Reviews in Oncology/Hematology Open access 9 Dec 2023 36
2 A phase I randomized, double‐blinded , placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects Jason D. Lickliter, Shuang Wang, Wenxin Zhang et al. · Clinical and Translational Science Open access 24 Jun 2023 23
3 Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target Yini Wang, Bowen Zhong, Caixia Xu et al. · iScience Open access 28 Jan 2023 21
4 First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors Ye Guo, Zishu Wang, Huan Zhou et al. · BMC Cancer Open access 10 Apr 2024 17
5 Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance Yazhou Wang, Yihong Zhang, Jinxin Liu et al. · Journal of Medicinal Chemistry Open access 31 Jan 2025 16
All 33 most cited papers, with filters and sorting

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genfleet Therapeutics (Shanghai) Inc. (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.